DK0768084T3 - Kræftmetastaseinhibitor - Google Patents

Kræftmetastaseinhibitor

Info

Publication number
DK0768084T3
DK0768084T3 DK96909329T DK96909329T DK0768084T3 DK 0768084 T3 DK0768084 T3 DK 0768084T3 DK 96909329 T DK96909329 T DK 96909329T DK 96909329 T DK96909329 T DK 96909329T DK 0768084 T3 DK0768084 T3 DK 0768084T3
Authority
DK
Denmark
Prior art keywords
benzoic acid
cancerous metastasis
metastasis inhibitor
coch
conh
Prior art date
Application number
DK96909329T
Other languages
Danish (da)
English (en)
Inventor
Jiro Shibata
Konstanty Wierzba
Yuji Yamada
Koichi Shudo
Koji Murakami
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0768084T3 publication Critical patent/DK0768084T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96909329T 1995-04-10 1996-04-10 Kræftmetastaseinhibitor DK0768084T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8380395 1995-04-10
PCT/JP1996/000980 WO1996032101A1 (fr) 1995-04-10 1996-04-10 Inhibiteur de la metastase cancereuse

Publications (1)

Publication Number Publication Date
DK0768084T3 true DK0768084T3 (da) 2002-10-14

Family

ID=13812829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96909329T DK0768084T3 (da) 1995-04-10 1996-04-10 Kræftmetastaseinhibitor

Country Status (12)

Country Link
US (1) US5750515A (ja)
EP (1) EP0768084B1 (ja)
JP (1) JP3208437B2 (ja)
KR (1) KR100207356B1 (ja)
AT (1) ATE223713T1 (ja)
AU (1) AU693682B2 (ja)
CA (1) CA2191850C (ja)
DE (1) DE69623555T2 (ja)
DK (1) DK0768084T3 (ja)
ES (1) ES2180751T3 (ja)
PT (1) PT768084E (ja)
WO (1) WO1996032101A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
KR20010063274A (ko) * 1999-12-22 2001-07-09 성재갑 〔1-｛〔1-（1,3-벤조디옥솔-5-일메틸-1ｈ-이미다졸-5-일〕메틸｝-4-(1-나프틸)-1ｈ-피롤-3-일〕（4-메틸-1-피페라지닐）메타논의 약학적 조성물
NO20003591L (no) * 2000-07-13 2002-01-14 Thia Medica As Fettsyreanaloger for behandling av kreft
DK1324970T3 (da) 2000-10-02 2009-01-05 Hoffmann La Roche Retinoider til behandling af emfysem
US8198328B2 (en) 2004-01-21 2012-06-12 New York University Treatment of cancer using benzoic acid derivatives
US20050202055A1 (en) * 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
US8415315B2 (en) 2004-05-06 2013-04-09 University Of Central Florida Research Foundation, Inc. Methods and compositions for inhibiting the proliferation of cancer cells
US20080275002A1 (en) * 2005-03-08 2008-11-06 Taiho Pharmaceutical Co., Ltd. Method for Treatment of Hepatic Cancer
WO2007049542A1 (ja) 2005-10-24 2007-05-03 Taiho Pharmaceutical Co., Ltd. RAR-α作動薬の有効性の予測方法
TW200922554A (en) 2007-10-11 2009-06-01 Taiho Pharmaceutical Co Ltd Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof
GB0915196D0 (en) 2009-09-01 2009-10-07 King S College London Therapeutic compounds and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5513238A (en) * 1978-07-17 1980-01-30 Banyu Pharmaceut Co Ltd Novel compound having immunoactivating action, its preparation and application
JP2752630B2 (ja) * 1988-03-29 1998-05-18 大鵬薬品工業株式会社 新規安息香酸誘導体及びその製造方法
JP2761023B2 (ja) * 1989-03-20 1998-06-04 大鵬薬品工業株式会社 新規安息香酸誘導体及びその製造方法
JPH0366647A (ja) * 1989-08-03 1991-03-22 Koichi Shudo フェニルベンゾエート誘導体
JPH03115289A (ja) * 1989-09-28 1991-05-16 Koichi Shudo 新規安息香酸誘導体、その製造方法及びその用途
JP3650144B2 (ja) * 1994-06-08 2005-05-18 花王株式会社 細胞接着抑制剤

Also Published As

Publication number Publication date
CA2191850C (en) 2002-06-18
DE69623555T2 (de) 2003-05-15
PT768084E (pt) 2002-12-31
AU5287596A (en) 1996-10-30
EP0768084A4 (en) 1999-05-06
KR970703761A (ko) 1997-08-09
AU693682B2 (en) 1998-07-02
KR100207356B1 (ko) 1999-07-15
ATE223713T1 (de) 2002-09-15
WO1996032101A1 (fr) 1996-10-17
DE69623555D1 (de) 2002-10-17
EP0768084B1 (en) 2002-09-11
EP0768084A1 (en) 1997-04-16
CA2191850A1 (en) 1996-10-17
JP3208437B2 (ja) 2001-09-10
US5750515A (en) 1998-05-12
ES2180751T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
DK0941218T3 (da) Antithrombotiske organiske nitrater
BG103485A (en) Ketobanzamides as calpain inhibitors
NO970495L (no) Aryltioforbindelser som anti-bakterielle og antivirale midler
DE60301345D1 (de) Stabilisierte askorbinsäurederivate
DK0768084T3 (da) Kræftmetastaseinhibitor
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
NO20092832L (no) Fremgangsmate for karbonylering av en forbindelse
TWI265929B (en) Triazinyl derivatives for inhibiting the production of IL-12
AU591860B2 (en) Pyrolidineamide derivative having anti-prolyl endopeptidase
ATE154347T1 (de) Benzisothiazolinon-1-dioxyde als elastase- inhibitoren
WO2005046672A3 (fr) Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose
NO932147L (no) Antiallergiske forbindelser
DE3677471D1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
YU47298B (sh) Derivati 16-dehidro-vitamina d3
EP0292576A4 (en) Anti-ulcerous agent containing chalcone derivative as effective ingredient and novel chalcone derivatives
SE0004101D0 (sv) New use
FI954138A (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
ID22762A (id) Komposisi untuk mengobati atau mencegah kanker prostat
SE9802546D0 (sv) Medicinal product and method for treatment and prevention of dyskinesia
ES2177623T3 (es) Composiciones farmaceuticas que contienen ceftriaxona y penems.
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
TR200000753T2 (tr) Mukabil antifungal ajan için prodrog olarak tetrahidrofuran fosfat ve hidroksi esterleri.
DK0619817T3 (da) Hidtil ukendte farmaceutisk aktive flaviliumforbindelser
ATE293605T1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren